Exosens
€59.20Change from previous close: +0.17%Absolute change: +€0.10
At a glance
- Revenue growth
- −18.11%
- 2025 vs 2024
- Net income growth
- −28.10%
- 2025 vs 2024
- Net margin
- 8.0%
- 2024: 9.1%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 879 | 817 | 656 | 529 | — |
| Current assets | 280 | 314 | 193 | 145 | — |
| Cash and equivalents | 68.6 | 117 | 15.5 | 29.0 | — |
| Short-term investments | 33.3 | 33.0 | 0.1 | 0.1 | — |
| Inventory | 105 | 93.0 | 78.5 | 55.7 | — |
| Net property, plant and equipment | 128 | 104 | 82.8 | 60.5 | — |
| Goodwill | 233 | 190 | 174 | 140 | — |
| Other intangible assets | 226 | 205 | 202 | 181 | — |
| Long-term investments | 3.8 | 3.4 | 3.4 | 2.8 | — |
| Current liabilities | 114 | 107 | 110 | 72.5 | — |
| Accounts payable | 31.2 | 26.0 | 32.3 | 22.9 | — |
| Long-term debt | — | — | 296 | 235 | 199 |
| Total debt | 16.6 | 10.9 | 312 | 249 | — |
| Total liabilities | 433 | 404 | 452 | 346 | — |
| Total equity (incl. minority) | 446 | 413 | 204 | 183 | — |
| Retained earnings | — | — | — | — | -149 |
| Minority interest | — | — | — | — | 0.0 |